Search | IOVS | ARVO Journals

Showing 1 – 18 of 18

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Association of early macular leakage resolution with extended dosing intervals in patients with RVO: A BALATON/COMINO post hoc analysis

Harit K Bhatt; Nicholas Dagincourt; Liliana Paris Pereira; Joern Schweitzer; Jan Thommen

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4688.

ARVO Annual Meeting Abstract June 2024

Efficacy, safety, and durability of faricimab in macular edema due to retinal vein occlusion: 72-week results from the BALATON and COMINO trials

Faruque Ghanchi; Francis Abreu; Pablo Arrisi; Aachal Kotecha; Ying Liu; Liliana P Paris; Anne-Cecile Retiere; Jeffrey R Willis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3124.

ARVO Annual Meeting Abstract June 2024

Treatment outcomes with anti-VEGF therapy for retinal vein occlusion: an analysis of real-world data from 16 UK sites

Christiana Dinah; Melanie Dodds; Pablo Arrisi; Liliana Paris Pereira; Alice Lake; Patrick Nielsen; John Holdsworth; Insaf Saffar; Gloria Chi

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6285.

ARVO Annual Meeting Abstract June 2023

A large-scale genetic analysis of inherited retinal diseases in the Portuguese population identifies a unique pattern of mutations

Karolina Kaminska; Virginie Gisele Peter; Cristina Santos; Mathieu Quinodoz; Francesca Cancellieri; Katarina Cisarova; Rosanna Pescini Gobert; Raquel Rodriguez; Sónia Custódio; Liliana P Paris; Ana Berta Sousa; Luisa Coutinho Santos; Carlo Rivolta

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2792.

ARVO Annual Meeting Abstract June 2021

Barriers to adherence to age-related macular degeneration and diabetic macular edema management plans: A multi-national qualitative study

Nancy M Holekamp; Sally Lanar; Jérémy Lambert; Michael Acquadro; Matthew Miera; Mirela Mirt Dabic; Aachal Kotecha; Liliana P. Paris; Iris Van den Brande; Brittany Gentile; Gloria Chi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1130.

ARVO Annual Meeting Abstract June 2017

Clinical features and a novel CHM mutation in a Portuguese family with X-linked choroideremia

Liliana P Paris; Márcia Rodrigues; Luísa Coutinho-Santos

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1489.

ARVO Annual Meeting Abstract September 2016

β-catenin in retinal interneurons is important for maintaining stability of the retinal microvasculature

Yoshihiko Usui; Peter D Westenskow; Toshihide Kurihara; Edith Aguilar; Liliana P Paris; Susumu Sakimoto; Salome Murinello; Felicitas Bucher; Daniel Feitelberg; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2762.

ARVO Annual Meeting Abstract September 2016

Reducing retinal oxidative metabolism to arrest progression of ischemic retinopathies

Liliana P Paris; Marin L Gantner; Peter D Westenskow; Tim U Krohne; Edith Aguilar; Yoshihiko Usui; Jennifer K Trombley; Daniel Feitelberg; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):103.

ARVO Annual Meeting Abstract June 2015

Neurovascular crosstalk between retinal interneurons and intraretinal capillaries is required for murine visual function

Yoshihiko Usui; Peter D Westenskow; Toshihide Kurihara; Edith Aguilar; Susumu Sakimoto; Liliana P Paris; Carli M Wittgrove; Daniel Feitelberg; Stacey K Moreno; Martin Friedlander; No

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3234.

ARVO Annual Meeting Abstract June 2015

Human iPSC-derived retinal pigment epithelium allografts are stable for over two years and do not elicit detrimental effects in rats

Daniel Feitelberg; Peter D Westenskow; Stephen Bravo; Toshihide Kurihara; Felicitas Bucher; Liliana P Paris; Edith Aguilar; Carli M Wittgrove; Jonathan H. Lin; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1838.

ARVO Annual Meeting Abstract June 2015

Prominent arginine-proline metabolic pathway perturbations characterize human proliferative diabetic retinopathy and the oxygen-induced-retinopathy mouse model

Liliana P Paris; Caroline H. Johnson; Edith Aguilar; Daniel Feitelberg; Yoshihiko Usui; Kinya Tsubota; Shunichiro Ueda; Yoshihiro Wakabayashi; Gary Siuzdak; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5203.

ARVO Annual Meeting Abstract April 2014

Induced Pluripotent Stem Cell-derived Tissues Elicit Selective Immunogenicity

Daniel Feitelberg; Peter D Westenskow; Stephen Bravo; Tongbiao Zhao; Zhili Rong; Carli M Wittgrove; Liliana P Paris; Dennis O Clegg; Yang Xu; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2673.

ARVO Annual Meeting Abstract April 2014

Amacrine cell-derived VEGF is required for development and maintenance of the retinal vasculature in mice

Yoshihiko Usui; Toshihide Kurihara; Peter D Westenskow; Edith Aguilar; Liliana P Paris; Stacey K Moreno; Carli M Wittgrove; Daniel Feitelberg; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3015.

ARVO Annual Meeting Abstract April 2014

Angiogenin is a potent modulator of neovascularization and inflammation that is upregulated in various human retinal diseases

Carli M Wittgrove; Liliana P Paris; Yoshihiko Usui; Yoshihiro Wakabayashi; Edith Aguilar; Daniel Feitelberg; Peter D Westenskow; Leah C Byrne; John Gerard Flannery; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2242.

ARVO Annual Meeting Abstract April 2014

Identification of a metabolite that can prevent features associated with proliferative diabetic retinopathy

Liliana P Paris; Caroline H Johnson; Peter D Westenskow; Yoshihiko Usui; Edith Aguilar; Daniel Feitelberg; Kinya Tsubota; Shunichiro Ueda; Gary Siuzdak; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4926.

ARVO Annual Meeting Abstract June 2013

M-CSF Inhibition Prevents the Formation of Outer Retinal Neovascularization in a Murine Model of Macular Telangiectasia

Edith Aguilar; Toshihide Kurihara; Peter Westenskow; Stephen Bravo; Carli Wittgrove; Liliana Paris; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3847.

ARVO Annual Meeting Abstract June 2013

RPE-specific VEGF Deletion Induces Geographic Atrophy: a Long-term Study

Liliana Paris; Toshihide Kurihara; Peter Westenskow; Stephen Bravo; Carli Wittgrove; Edith Aguilar; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):365.

ARVO Annual Meeting Abstract June 2013

iPS-RPE implantation in the Royal College of Surgeons Rat does not lead to adverse events in a long term study of health and graft stability

Stephen Bravo; Peter Westenskow; Toshihide Kurihara; Alison Dorsey; Liliana Paris; Jonathan Lin; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5811.

NARROW

Content Type

Journal

Article Type

Specify Date Range

Association of early macular leakage resolution with extended dosing intervals in patients with RVO: A BALATON/COMINO post hoc analysis

Efficacy, safety, and durability of faricimab in macular edema due to retinal vein occlusion: 72-week results from the BALATON and COMINO trials

Treatment outcomes with anti-VEGF therapy for retinal vein occlusion: an analysis of real-world data from 16 UK sites

A large-scale genetic analysis of inherited retinal diseases in the Portuguese population identifies a unique pattern of mutations

Barriers to adherence to age-related macular degeneration and diabetic macular edema management plans: A multi-national qualitative study

Clinical features and a novel CHM mutation in a Portuguese family with X-linked choroideremia

β-catenin in retinal interneurons is important for maintaining stability of the retinal microvasculature

Reducing retinal oxidative metabolism to arrest progression of ischemic retinopathies

Neurovascular crosstalk between retinal interneurons and intraretinal capillaries is required for murine visual function

Human iPSC-derived retinal pigment epithelium allografts are stable for over two years and do not elicit detrimental effects in rats

Prominent arginine-proline metabolic pathway perturbations characterize human proliferative diabetic retinopathy and the oxygen-induced-retinopathy mouse model

Induced Pluripotent Stem Cell-derived Tissues Elicit Selective Immunogenicity

Amacrine cell-derived VEGF is required for development and maintenance of the retinal vasculature in mice

Angiogenin is a potent modulator of neovascularization and inflammation that is upregulated in various human retinal diseases

Identification of a metabolite that can prevent features associated with proliferative diabetic retinopathy

M-CSF Inhibition Prevents the Formation of Outer Retinal Neovascularization in a Murine Model of Macular Telangiectasia

RPE-specific VEGF Deletion Induces Geographic Atrophy: a Long-term Study

iPS-RPE implantation in the Royal College of Surgeons Rat does not lead to adverse events in a long term study of health and graft stability

To View More...

You must be signed into an individual account to use this feature.